BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: ElHady AK, El-Gamil DS, Chen PJ, Hwang TL, Abadi AH, Abdel-Halim M, Engel M. 5-Methoxybenzothiophene-2-Carboxamides as Inhibitors of Clk1/4: Optimization of Selectivity and Cellular Potency. Molecules 2021;26:1001. [PMID: 33668683 DOI: 10.3390/molecules26041001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 El-Gamil DS, ElHady AK, Chen PJ, Hwang TL, Abadi AH, Abdel-Halim M, Engel M. Discovery of novel 5-methoxybenzothiophene hydrazides as metabolically stable Clk1 inhibitors with high potency and unprecedented Clk1 isoenzyme selectivity. Eur J Med Chem 2023;247:115019. [PMID: 36580731 DOI: 10.1016/j.ejmech.2022.115019] [Reference Citation Analysis]
2 ElHady AK, El-Gamil DS, Abadi AH, Abdel-Halim M, Engel M. An overview of cdc2-like kinase 1 (Clk1) inhibitors and their therapeutic indications. Med Res Rev 2022. [PMID: 36262046 DOI: 10.1002/med.21928] [Reference Citation Analysis]
3 Belal A, Elkady H, Al-karmalawy AA, Amin AH, Ghoneim MM, El-sherbiny M, Al-serwi RH, Abdou MA, Ibrahim MH, Mehany ABM. Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations. Molecules 2022;27:5571. [DOI: 10.3390/molecules27175571] [Reference Citation Analysis]
4 El-gamil DS, Elhady AK, Chen P, Hwang T, Abadi AH, Abdel-halim M, Engel M. Development of novel conformationally restricted selective Clk1/4 inhibitors through creating an intramolecular hydrogen bond involving an imide linker. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]